Texas Senate Bill SB1301

Texas 2011 - 82nd Regular

• Out of Senate Committee: 4/7/11
• Introduced: 3/8/11
• Voted on by Senate: 4/13/11
• Refer: 3/16/11
• Out of House Committee: 5/20/11
• Report Pass: 4/7/11
• Engrossed: 4/13/11
• Refer: 4/14/11
• Report Pass: 5/19/11

Caption

Relating to manufacturers' inclusion of denatonium benzoate in certain products containing ethylene glycol.

Impact

The implementation of SB 1301 will impact manufacturers of antifreeze and engine coolants by obligating them to comply with the specific formulation guidelines outlined in the bill. Companies must maintain detailed records regarding the denatonium benzoate used in their products and make this information available upon request. Moreover, the bill provides manufacturers with a liability shield, meaning they will not be held responsible for damages or injuries directly linked to the inclusion of the bittering agent, unless the liability arises from non-compliance with the regulations. This legal protection is significant as it encourages manufacturers to adopt safer practices without the fear of litigation stemming from the mandatory use of the additive.

Summary

Senate Bill 1301 mandates that manufacturers include denatonium benzoate, a bittering agent, in products containing more than 10% ethylene glycol, specifically antifreeze or engine coolants. This requirement applies to products manufactured after January 1, 2013, and ensures that these products contain between 30 and 50 parts per million of the additive. The addition of denatonium benzoate is aimed at preventing accidental poisoning, particularly in situations where individuals or animals may inadvertently consume these products. The bill is part of broader safety regulations pertaining to hazardous materials and reflects an increased awareness of public health and safety risks associated with toxic substances.

Contention

Despite the focus on enhancing public safety, the bill is not without its controversies. Some critics have raised concerns regarding the adequacy of safety regulations concerning toxic substances, arguing that simply adding a bittering agent is not sufficient to address the broader issue of chemical exposure. Additionally, there are concerns about the enforcement of the law and whether adequate measures will be in place to ensure compliance among manufacturers. Opponents have also suggested that the bill could impose additional costs on producers, which may ultimately affect prices for consumers. Balancing product safety and economic considerations remains a contentious aspect of the legislation.